Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a 6.564\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a CC(=O)N1CCN(S(=O)(=O)c2cccc(C(=O)OCc3cccc(F)c3)c2)CC1
b COc1ccc(N2CCN(C(c3ccc4ncccc4c3)c3nnnn3C(C)C)CC2)cc1
c CCC(C)(C(=O)NC1CCCC1)N(C)C(=O)c1ccccn1
Answer: c. CCC(C)(C(=O)NC1CCCC1)N(C)C(=O)c1ccccn1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(C)(C(=O)NC1CCCC1)N(C)C(=O)c1ccccn1
CCC(C)(C(=O)NC1CCCC1)N(C)C(=O)c1ccccn1
N-[1-(cyclopentylamino)-2-methyl-1-oxobutan-2-yl]-N-methylpyridine-2-carboxamide